Abstract
In a set of four increasingly multidrug-resistant variants of SW-1573 human lung tumor cells, the pHi (i.e., steady-state cytosolic pH) increased up to 0.44 U as a function of the level of doxorubicin resistance. The elevated pHi in the most resistant (2,000-fold) variant dropped to the control level upon addition of verapamil, a known inhibitor of P-glycoprotein activity. These data suggest that, in the absence of xenobiotic substrates, P-glycoprotein activity can affect cellular pHi. This finding may be important for the elucidation of the physiological function of this protein.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
ATP Binding Cassette Transporter, Subfamily B, Member 1
-
Carrier Proteins / analysis
-
Cytosol / metabolism
-
Doxorubicin / pharmacology
-
Drug Resistance
-
Humans
-
Hydrogen-Ion Concentration
-
Lung Neoplasms / pathology
-
Membrane Glycoproteins / analysis*
-
Sodium-Hydrogen Exchangers
-
Tetradecanoylphorbol Acetate / pharmacology
-
Tumor Cells, Cultured
-
Verapamil / pharmacology*
Substances
-
ATP Binding Cassette Transporter, Subfamily B, Member 1
-
Carrier Proteins
-
Membrane Glycoproteins
-
Sodium-Hydrogen Exchangers
-
Doxorubicin
-
Verapamil
-
Tetradecanoylphorbol Acetate